BETHESDA, MD – The 2024 ACMG Annual Clinical Genetics Meeting will be in Toronto, Canada on March 12-16, 2024. This annual medical and scientific conference continues to provide groundbreaking research and the latest advances in medical genetics, genomics and personalized medicine. The 2024 ACMG Annual Clinical Genetics Meeting will offer media a firsthand look at what is shaping the future of genetics and genomics in medicine and will offer a variety of engaging and interactive educational formats and types of sessions—from Scientific Sessions and Workshops to TED-Style Talks, Case-based Sessions, Platform Presentations and Short Courses.
Interview those at the forefront in medical genetics and genomics, connect with new sources, and get story ideas on the clinical practice of genetics and genomics in healthcare today and for the future. Learn how genetics and genomics research is being integrated and applied in medical and lab practice. Topics include artificial intelligence in genetics, gene editing, reproductive genetics, cancer genetics, direct-to-consumer genetic testing, exome sequencing, pre- and perinatal genetics, the importance of diversity, equity and inclusion in the study of genetics, biochemical/metabolic genetics, genetic counseling, health services and implementation, legal and ethical issues, therapeutics and more.
For further details about the congress, including registration, please click here.
Credentialed media representatives on assignment are invited to cover the ACMG Annual Meeting on a complimentary basis. Contact Kathy Moran, MBA at [email protected] for the Press Registration Invitation Code, which will be needed to register at www.acmgmeeting.net.
Credentialed media can also request access to the OnDemand sessions available after the in-person meeting.
Abstracts will be available in March 2024 and will be published as a supplement to Genetics in Medicine Open.
Program Highlights:
- 2024 ACMG Foundation Awards and Presidential Plenary Session: Inquiry and Innovation – How Far Have We Come and How Far Can We Go?
- Genome Sequencing in Newborn Screening: Sharing Opportunities and Challenges
- The Clinical Use of Polygenic Risk Scores in Breast Cancer Risk Prediction
- To Treat or Not to Treat: Dilemmas for Rare Diseases Care in A New Therapeutic Era
- Diagnostic Dilemmas “True Unknowns” from the Undiagnosed Diseases Network
- Cardiomyopathy: When is it an Inborn Error of Metabolism?
- After Dobbs: Impact of Abortion Laws on Genetics and Genomics Training & Practice
- Body Image, Contraception, Fertility, and Beyond: The Health of Women with Genetic Disorders
- ACMG/AMP/CAP/ClinGen Standards for Sequence and Copy Number Variant Classification
- Navigating Crossroads of Complex Adult-Onset Neurological Diseases and Neurometabolic Disorders
These activities are supported by independent educational grants from the companies noted below.
- Implementing Gene Therapies into Your Genetics Clinic: Learnings from Other Specialties (Ultragenyx Pharmaceutical Inc)
- Equitable Access to Exomes and Genomes. Ordered by Whom? (GeneDx)
- Optimizing Care for Patients with Fabry Disease: Interactive Case Challenges (Amicus Therapeutics)
- An Evolving Role in An Evolving Landscape: Genetic Counselors & Clinical Geneticists (Sarepta Therapeutics)
- Optimizing Care for Patients with Fabry Disease: Interactive Case Challenges (This activity is sponsored by Amicus Therapeutics)
- Metabolic Diseases: Strategies to Improve Management of Porphyrias and Porphyria-like Attacks (Recordati Rare Diseases)
Meeting at a glance
When: March 16-20 2024
Venue: Metro Toronto Convention Centre – 255 Front St W Toronto, ON M5V 2W6
About the American College of Medical Genetics and Genomics (ACMG) and ACMG Foundation
Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) is a prominent authority in the field of medical genetics and genomics and the only nationally recognized medical professional organization solely dedicated to improving health through the practice of medical genetics and genomics. The only medical specialty society in the US that represents the full spectrum of medical genetics disciplines in a single organization, the ACMG provides education, resources and a voice for more than 2,500 clinical and laboratory geneticists, genetic counselors and other healthcare professionals. ACMG’s mission is to improve health through the clinical and laboratory practice of medical genetics as well as through advocacy, education and clinical research, and to guide the safe and effective integration of genetics and genomics into all of medicine and healthcare, resulting in improved personal and public health. Genetics in Medicine and the new Genetics in Medicine Open, a gold open access journal, are the official ACMG journals. ACMG’s website, www.acmg.net, offers resources including policy statements, practice guidelines, and educational programs. The ACMG Foundation for Genetic and Genomic Medicine works to advance ACMG educational and public health programs through charitable gifts from corporations, foundations and individuals.